Clinical Trial Update: Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating RGL-270 alone and in combination with Adebelimab for high-risk recurrence after radical treatment of malignant solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Adebelimab (adebelimab)
• RGL-270

Snippet

Sponsor: Xian-Jun Yu | Conditions: Tumor, Solid | Phase 1 | Status: RECRUITING